Monoclonale antibody: Mouse anti-human complement Factor H

Scientists at the Georg-August-University produced monoclonal antibodies which react with the polymorphic variant of human complement Factor H (FH-402(His), a marker for age-related macular degeneration. These peptide-specific antibodies specifically react with the polymorphic variants of human complement Factor H (either FH-402Y or FH-402H). Therefor they can be used for the screening of individuals at risk for developing AMD, as well as for the functional characterization of complement Factor H variants. AMD is the leading cause of blindness in the elderly. Because there is the chance to treat AMD with a new drug ( anti-VEGF-antibodies) nowadays this would increase the value of a new diagnostic screening assay.

Further Information: PDF

MBM ScienceBridge GmbH
Phone: (0551) 30724-151

Contact
Dr. Jens-Peter Horst

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Detector for continuously monitoring toxic gases

The material could be made as a thin coating to analyze air quality in industrial or home settings over time. Most systems used to detect toxic gases in industrial or…

On the way for an active agent against hepatitis E

In order to infect an organ, viruses need the help of the host cells. “An effective approach is therefore to identify targets in the host that can be manipulated by…

A second chance for new antibiotic agent

Significant attempts 20 years ago… The study focused on the protein peptide deformylase (PDF). Involved in protein maturation processes in cells, PDF is essential for the survival of bacteria. However,…

Partners & Sponsors